CLDN4 and neoplasm: In contrast, our study of both primary and secondary lesions examined 182 sections from patients with a range of prostate conditions to provide a better understanding of the role of claudin-4 in the prostate and in tumour progression: our findings are consistent with current concepts of the carcinogenesis/invasion process.